|
Volumn 29, Issue 3, 2001, Pages 127-137
|
Antimicrobial expenditures and usage at four university hospitals
|
Author keywords
Antibiotic cost; Antibiotic use; Health economics; Hospital expenditures; Infectious disease service; Pharmacoepidemiology; Quality management
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
ANTIINFECTIVE AGENT;
ANTIVIRUS AGENT;
BETA LACTAM ANTIBIOTIC;
CEPHALOSPORIN DERIVATIVE;
CLINDAMYCIN;
COTRIMOXAZOLE;
GLYCOPEPTIDE;
IMIPENEM;
MACROLIDE;
METRONIDAZOLE;
PENICILLIN DERIVATIVE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
ARTICLE;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG USE;
HEALTH CARE COST;
PHARMACOEPIDEMIOLOGY;
PRESCRIPTION;
TREATMENT INDICATION;
UNIVERSITY HOSPITAL;
ADOLESCENT;
ADULT;
AGED;
ANTI-BACTERIAL AGENTS;
CHILD;
COSTS AND COST ANALYSIS;
DIAGNOSIS-RELATED GROUPS;
DRUG COSTS;
HEALTH EXPENDITURES;
HEALTH SURVEYS;
HOSPITAL COSTS;
HUMANS;
MEDICAL AUDIT;
MIDDLE AGED;
PHYSICIAN'S PRACTICE PATTERNS;
QUALITY ASSURANCE, HEALTH CARE;
|
EID: 0034983626
PISSN: 03008126
EISSN: None
Source Type: Journal
DOI: 10.1007/s15010-001-1075-0 Document Type: Article |
Times cited : (19)
|
References (47)
|